Toviaz is a prescription medication used to treat overactive bladder (OAB), a condition that causes frequent, urgent, and hard-to-control urges to urinate. It comes as an extended-release tablet taken once daily and works by relaxing the bladder muscle to reduce urgency, frequency, and episodes of urinary incontinence.
How Toviaz Treats Overactive Bladder
Overactive bladder happens when the muscle surrounding the bladder contracts involuntarily, creating a sudden urge to urinate even when the bladder isn’t full. This can lead to going to the bathroom eight or more times a day, waking up multiple times at night, and sometimes leaking urine before you can reach a toilet.
Toviaz contains the active ingredient fesoterodine, which blocks chemical signals that tell the bladder muscle to squeeze. By calming those involuntary contractions, it gives the bladder more time to fill before you feel the urge to go. The medication is available in two strengths: 4 mg and 8 mg. Most people start at the lower dose, and if symptoms don’t improve enough, their prescriber may increase it.
What the Clinical Evidence Shows
In clinical trials, Toviaz significantly reduced several hallmarks of overactive bladder compared to placebo. People taking the medication had fewer total bathroom trips per day, fewer urgency episodes, and fewer nighttime urges that disrupted sleep. Nighttime urination episodes also decreased significantly. These improvements were consistent across both men and women.
One area where results were less clear-cut was urgency urinary incontinence, the involuntary leaking that comes with a sudden urge. In one trial, the reduction in leaking episodes was not statistically different from placebo, meaning the medication’s strongest benefits appear to be in reducing how often you feel the urge and how many times you actually go rather than preventing leaks specifically.
How Long It Takes to Work
You may notice some improvement within the first few weeks of starting Toviaz. However, the full benefit can take up to 12 weeks to develop. This is a medication that rewards patience, so it’s worth sticking with the prescribed course before judging whether it’s working well enough for you.
Common Side Effects
Because Toviaz works by blocking certain chemical receptors, it affects more than just the bladder. The same receptors exist in salivary glands, the digestive tract, and elsewhere, which is why side effects tend to involve dryness and slowed digestion.
Dry mouth is the most common complaint. In pooled clinical trials, 22% of people taking the 4 mg dose and 35% of those on the 8 mg dose experienced it, compared to 8% on placebo. Constipation was the second most reported issue, affecting about 3% at the lower dose and 5% at the higher dose. Both side effects are dose-dependent, meaning they’re more likely and more noticeable at 8 mg than at 4 mg. For many people, dry mouth is manageable with sugar-free lozenges or frequent sips of water, though some find it bothersome enough to switch medications.
Who Should Not Take Toviaz
Toviaz is not appropriate for everyone with bladder symptoms. The FDA lists several conditions where the medication is strictly off-limits:
- Urinary retention: if you already have difficulty emptying your bladder, Toviaz can make it worse by further relaxing the bladder muscle.
- Gastric retention: the same relaxing effect can slow the stomach and intestines, which is dangerous if you already have delayed gastric emptying.
- Uncontrolled narrow-angle glaucoma: Toviaz can increase eye pressure in susceptible people, risking vision damage.
- Known allergy: anyone who has had a reaction to Toviaz, its ingredients, or the related medication tolterodine should avoid it. Allergic reactions have included angioedema, a serious swelling of the face, lips, or throat.
Generic Availability
As of now, Toviaz is still available primarily as a brand-name product. Sixteen applications for generic versions of fesoterodine extended-release tablets (in both 4 mg and 8 mg strengths) have been submitted to the FDA, but the last qualifying patent on the brand doesn’t expire until June 2027. Until then, generic alternatives are unlikely to reach the market, which means cost can be a factor. If affordability is a concern, it’s worth checking the manufacturer’s website for savings programs or asking your pharmacist about discount options.
How Toviaz Compares to Other OAB Medications
Toviaz belongs to a class of bladder-calming medications that includes several other options like oxybutynin, tolterodine, and solifenacin. All of them work through a similar mechanism. What distinguishes Toviaz is that after you swallow it, your body converts it into the same active compound produced by tolterodine, but through a more predictable metabolic pathway. In practical terms, this means the blood levels of the active compound are more consistent from person to person, which can translate to more reliable dosing.
The tradeoff is familiar across this entire drug class: the more effective the dose, the more pronounced the dry mouth and constipation. If you’ve tried one medication in this category and found it either ineffective or too drying, switching to another (including Toviaz) is a reasonable next step, since individual responses vary quite a bit.